Jazz Pharmaceuticals

BIO: Jazz is auditioning new bandmates in an M&A market ripe with talent
BIO: Jazz is auditioning new bandmates in an M&A market ripe with talent
Fierce Biotech
Jazz Pharmaceuticals
Bruce Cozadd
M&A
BIO 2023
neurology
oncology
Flag link:
Jazz wins reimbursement nod from NICE for cannabinoid med Epidyolex
Jazz wins reimbursement nod from NICE for cannabinoid med Epidyolex
Fierce Pharma
Jazz Pharmaceuticals
Epidyolex
UK
NICE
cannabinoids
Flag link:
Competition is on the horizon for costly narcolepsy treatments
Competition is on the horizon for costly narcolepsy treatments
Pharmaphorum
narcolepsy
Jazz Pharmaceuticals
Molina Healthcare
Avadel
Harmony Biosciences
Flag link:
Jazz plays coda to blood cancer approval, securing FDA nod for revised dosing schedule
Jazz plays coda to blood cancer approval, securing FDA nod for revised dosing schedule
Fierce Pharma
Jazz Pharmaceuticals
FDA
Rylaze
blood cancer
acute lymphoblastic leukemia
lymphoblastic lymphoma
Flag link:
FTC Amicus Brief Challenges Abuse of FDA “Orange Book” Listing Procedures to Block Drug Competition
FTC Amicus Brief Challenges Abuse of FDA “Orange Book” Listing Procedures to Block Drug Competition
FTC
legal
FTC
Orange Book
Jazz Pharmaceuticals
Avadel Pharma
patents
competition
Flag link:
FDA Keeps Jazz’s SCLC Treatment on the Market Despite Failed Confirmatory Trial
FDA Keeps Jazz’s SCLC Treatment on the Market Despite Failed Confirmatory Trial
BioSpace
Jazz Pharmaceuticals
FDA
Zepzelca
small cell lung cancer
Flag link:
FDA explains why it won't pull Jazz's accelerated approval despite a failed confirmatory trial
FDA explains why it won't pull Jazz's accelerated approval despite a failed confirmatory trial
Endpoints
Jazz Pharmaceuticals
FDA
metastatic small cell lung cancer
lung cancer
Zepzelca
Flag link:
Buy now, pay later: Jazz hands over $50M for Zymeworks' phase 3 HER2-directed bispecific
Buy now, pay later: Jazz hands over $50M for Zymeworks' phase 3 HER2-directed bispecific
Fierce Biotech
Jazz Pharmaceuticals
Zymeworks
HER2 inhbitor
bispecific antibodies
Flag link:
Few biopharma risers stand out at the half year
Few biopharma risers stand out at the half year
EP Vantage
Lantheus Medical
Vertex Pharmaceuticals
Jazz Pharmaceuticals
COVID-19
Flag link:
CEL-SCI, Jazz, CARsgen, Ascentage and Portage Showcase New Data at ASCO
CEL-SCI, Jazz, CARsgen, Ascentage and Portage Showcase New Data at ASCO
BioSpace
ASCO 2022
oncology
Cel-Sci
Jazz Pharmaceuticals
CARsgen
Ascentage
Portage
Rylaze
Multikine
olverembatinib
CT041
Flag link:
Jazz, Werewolf to howl at the moon together in $1.26B backloaded biobucks pact
Jazz, Werewolf to howl at the moon together in $1.26B backloaded biobucks pact
Fierce Biotech
Jazz Pharmaceuticals
Werewolf Therapeutics
biobucks
tumors
WTX-613
Flag link:
Rare disease and neurology take outs tick higher
Rare disease and neurology take outs tick higher
EP Vantage
M&A
AbbVie
AstraZeneca
Bristol Myers Squibb
JNJ
Gilead Sciences
Jazz Pharmaceuticals
Merck
Pfizer
Sanofi
rare disease
neurology
Flag link:
In a quiet year for takeouts, who was buying?
In a quiet year for takeouts, who was buying?
EP Vantage
M&A
Jazz Pharmaceuticals
Horizon Pharma
MorphoSys
Flag link:
Xywav Narcolepsy Drug Scores FDA Approval for Rare Sleep Disorder
Xywav Narcolepsy Drug Scores FDA Approval for Rare Sleep Disorder
Xtalks
Jazz Pharmaceuticals
Xywav
narcolepsy
Flag link:
FDA approves expanded use of Jazz Pharma's sleep disorder drug Xywav
FDA approves expanded use of Jazz Pharma's sleep disorder drug Xywav
Yahoo/Reuters
Jazz Pharmaceuticals
Xywav
FDA
idiopathic hypersomnia
Flag link:
Biotech M&A tracker: After hitting new heights, deals have slowed down. Here are the latest.
Biotech M&A tracker: After hitting new heights, deals have slowed down. Here are the latest.
BioPharma Dive
M&A
Bayer
Sanofi
Amgen
uniQure
MorphoSys
Xeris Pharmaceuticals
Relay Therapeutics
Merck
Beam Therapeutics
Jazz Pharmaceuticals
Flag link:
Jazz Pharma (JAZZ) Gets FDA Approval for Leukemia Drug Rylaze
Jazz Pharma (JAZZ) Gets FDA Approval for Leukemia Drug Rylaze
Yahoo/Zacks.com
Jazz Pharmaceuticals
FDA
Rylaze
JZP-458
acute lymphoblastic leukemia
lymphoblastic lymphoma
Flag link:
Jazz recognizes less-common small cell lung cancer patients' needs with new online initiative
Jazz recognizes less-common small cell lung cancer patients' needs with new online initiative
Fierce Pharma
Jazz Pharmaceuticals
patient education
small cell lung cancer
Flag link:
Jazz Pharmaceuticals (JAZZ) Beats Q1 Earnings and Revenue Estimates
Jazz Pharmaceuticals (JAZZ) Beats Q1 Earnings and Revenue Estimates
Yahoo/Zacks.com
Jazz Pharmaceuticals
earnings
Flag link:
FDA grants 'Priority Review' status to Jazz Pharmaceuticals' Xywav
FDA grants 'Priority Review' status to Jazz Pharmaceuticals' Xywav
Seeking Alpha
Jazz Pharmaceuticals
Flag link:

Pages